[HTML][HTML] Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs

RJ Duintjer Tebbens, KM Thompson - BMC infectious diseases, 2015 - Springer
Abstract Background The Global Polio Eradication Initiative plans for coordinated cessation
of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (ie, OPV2
cessation) followed by the remaining two OPV serotypes (ie, OPV13 cessation). The risk of
circulating vaccine-derived poliovirus (cVDPV) outbreaks after OPV cessation of any
serotype depends on the serotype-specific population immunity to transmission prior to its
cessation. Methods Based on an existing integrated global model of poliovirus risk …

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs.

RJD Tebbens, KM Thompson - 2015 - cabidigitallibrary.org
Abstract Background: The Global Polio Eradication Initiative plans for coordinated cessation
of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (ie, OPV2
cessation) followed by the remaining two OPV serotypes (ie, OPV13 cessation). The risk of
circulating vaccine-derived poliovirus (cVDPV) outbreaks after OPV cessation of any
serotype depends on the serotype-specific population immunity to transmission prior to its
cessation. Methods: Based on an existing integrated global model of poliovirus risk …
以上显示的是最相近的搜索结果。 查看全部搜索结果